Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Más filtros

Medicinas Tradicionales
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Med Food ; 25(10): 1003-1010, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-36179067

RESUMEN

Although lactose-free dairy products for the clinical management of lactose intolerance (LI) are widely available, scientific evidence on their efficacy is still lacking. This study comparatively analyzed the efficacy of flavored lactose-free milk (LFM) and whole milk (WM) in reducing symptoms in South Korean adults with LI. This prospective study was conducted in adults suspected of LI. All screened participants underwent the hydrogen breath test (HBT) using 570 mL of chocolate-flavored WM (20 g of lactose) and responded to a symptom questionnaire. LI was confirmed when the ΔH2 peak exceeded 16 ppm above baseline values and with the occurrence of symptoms after WM consumption. The participants who were diagnosed with LI underwent the HBT again with 570 mL of chocolate-flavored LFM (0 g of lactose), followed by the symptom questionnaire survey after 1 week. After excluding 40 participants who did not meet the diagnostic criteria for LI and 2 who were lost to follow-up, a total of 28 lactose-intolerant individuals were enrolled in the study. The ΔH2 values in the first HBT were significantly higher than those in the second HBT (33.3 ± 21.6 ppm vs. 8.6 ± 6.3 ppm, P < .001). Similarly, there was a significant reduction in the total symptom score in the second HBT (4.18 ± 1.51 vs. 0.61 ± 0.98, P < .001). Flavored LFM is well tolerated in South Korean adults diagnosed with LI based on the HBT and symptom questionnaire results. Therefore, LFM may be a viable alternative to WM.


Asunto(s)
Intolerancia a la Lactosa , Adulto , Humanos , Animales , Intolerancia a la Lactosa/diagnóstico , Intolerancia a la Lactosa/epidemiología , Lactosa , Leche/química , Estudios Prospectivos , Hidrógeno , República de Corea
2.
Nutrients ; 10(11)2018 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-30388735

RESUMEN

Milk is a fundamental component of the diet of every mammal; nevertheless, not every individual can tolerate this kind of food, especially in adulthood. However, lactose intolerance has only been recognized in the last 50 years, and currently, lactose intolerance is defined as a clinical syndrome characterized by pain, abdominal distention, flatulence, and diarrhoea that occur after lactose consumption. Lactose is currently a common disaccharide in human nutrition, both in breastfed infants and in adults, but its digestion requires a specialized enzyme called lactase. The genetically programmed reduction in lactase activity during adulthood affects most of the world's adult population and can cause troublesome digestive symptoms, which may also vary depending on the amount of residual lactase activity; the small bowel transit time; and, especially, the amount of ingested lactose. Several diagnostic tests are currently available for lactose intolerance, but the diagnosis remains challenging. The treatment for lactose intolerance mainly consists of reducing or eliminating the dietetic amount of lactose until the symptoms disappear, but this is hard to achieve, as lactose is present in dairy products and is even commonly used as a food additive. In addition to dietetic restriction of lactose-containing foods, lactase can be administered as an enzymatic food supplement, but its efficacy is still controversial. Recently, probiotics have been proposed for the management of lactose intolerance; certain probiotic strains have shown specific ß-galactosidase activity, thus aiding in the digestion of lactose. The aim of this paper was to review the current knowledge about lactose intolerance and to discuss the potential for the use of specific probiotic strains such as dietary supplements in lactose-intolerant patients.


Asunto(s)
Intolerancia a la Lactosa/diagnóstico , Lactosa/efectos adversos , Lactosa/metabolismo , Dieta , Humanos , Síndromes de Malabsorción
3.
Acta Paediatr ; 107(8): 1389-1394, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-29505134

RESUMEN

AIM: This study described outcomes following treatment for lactose intolerance, which is common in children. METHODS: The medical records of children aged 6-18 years who underwent lactose hydrogen breath testing at Dana-Dwek Children's Hospital, Tel Aviv, Israel, from August 2012 to August 2014 were analysed. We compared 154 children with gastrointestinal symptoms and positive lactose hydrogen breath tests to 49 children with negative test results. RESULTS: Of the 154 children in the study group, 89 (57.8%) were advised to follow a lactose-restricted diet, 32 (20.8%) were advised to avoid lactose completely, 18 (11.7%) were instructed to use substitute enzymes, and 15 (9.7%) did not receive specific recommendations. Only 11 patients (7.1%) received recommendations to add calcium-rich foods or calcium supplements to their diet. Lactose reintroduction was attempted in 119 of 154 patients (77.3%), and 65 of 154 (42.2%) experienced clinical relapses. At the final follow-up of 3.3 years, 62.3% of the study children were still observing a restricted diet. Older children and those who were symptomatic during lactose hydrogen breath testing were more likely to be on a prolonged restricted diet. CONCLUSION: Our long-term follow-up of lactose-intolerant children showed that only a third were able to achieve a regular diet.


Asunto(s)
Dieta , Enfermedades Gastrointestinales/dietoterapia , Enfermedades Gastrointestinales/fisiopatología , Intolerancia a la Lactosa/dietoterapia , Intolerancia a la Lactosa/diagnóstico , Calidad de Vida , Adolescente , Pruebas Respiratorias , Niño , Preescolar , Estudios de Cohortes , Bases de Datos Factuales , Femenino , Estudios de Seguimiento , Enfermedades Gastrointestinales/etiología , Hospitales Pediátricos , Humanos , Israel , Masculino , Recuperación de la Función , Estudios Retrospectivos , Medición de Riesgo , Estadísticas no Paramétricas , Factores de Tiempo
4.
Eur Ann Allergy Clin Immunol ; 48(5): 164-73, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27608472

RESUMEN

The proportion of people suffering or reporting to have a hypersensitivity caused by cow's milk consumption is increasing, and even health professionals often face difficulties into elaborating properly with a milk reaction due to misdiagnosis. The scope of this review is to present literature data that lead into putting the border line between cow's milk allergy and cow's milk intolerance, mainly focusing on how the different pathophysiology leads to their different dietary diagnosis and management.


Asunto(s)
Intolerancia a la Lactosa/dietoterapia , Hipersensibilidad a la Leche/dietoterapia , Calcio/administración & dosificación , Errores Diagnósticos , Suplementos Dietéticos , Humanos , Intolerancia a la Lactosa/diagnóstico , Intolerancia a la Lactosa/epidemiología , Intolerancia a la Lactosa/fisiopatología , Hipersensibilidad a la Leche/diagnóstico , Hipersensibilidad a la Leche/epidemiología , Hipersensibilidad a la Leche/fisiopatología , Estado Nutricional , Valor Predictivo de las Pruebas , Factores de Riesgo , Resultado del Tratamiento
5.
Orv Hetil ; 156(38): 1532-9, 2015 Sep 20.
Artículo en Húngaro | MEDLINE | ID: mdl-26550699

RESUMEN

Lactose intolerance is the most prevalent intestinal malabsorption disorder. After presentation of its history, the author describes the emergence of lactose intolerance during the evolution of species, and the biochemistry of lactose as well as features of human and bacterial lactase enzymes are then described. The unequal distribution of lactose intolerance in different continents and population is discussed, followed by presentation of past and present prevalence data in Hungary. Adult-type hypolactasia is caused by a polymorphism of the MCM6 gene located upstream from the lactase gene on the long arm of the chromosome 2. It can be determined with the polymerase chain reaction. The intestinal symptoms of lactose intolerance are well known, but its extra-intestinal manifestations are less recognised. Invasive diagnostic methods (determination of lactase activity from small intestinal biopsies, lactose tolerance test), are accurate, but have been replaced by the non-invasive methods; their gold standard is the H2 breath test. Genetic testing is being used more and more frequently in Hungary too, and, presumably, the methane breath test will be also available in the near future. Lactose intolerance can be accompanied by inflammatory bowel diseases, coeliac disease and irritable bowel syndrome; it could be established whether this association is causal or not in order to start a correct diet and therapy.


Asunto(s)
Pruebas Respiratorias , Pruebas Genéticas , Intolerancia a la Lactosa , Prueba de Tolerancia a la Lactosa , Lactosa/metabolismo , Polimorfismo de Nucleótido Simple , Animales , Biopsia , Enfermedad Celíaca/etiología , Europa (Continente) , Salud Global , Historia del Siglo XVII , Historia del Siglo XVIII , Historia del Siglo XIX , Historia Antigua , Humanos , Hungría/epidemiología , Enfermedades Inflamatorias del Intestino/etiología , Mucosa Intestinal/metabolismo , Síndrome del Colon Irritable/etiología , Lactasa/deficiencia , Lactosa/química , Intolerancia a la Lactosa/complicaciones , Intolerancia a la Lactosa/diagnóstico , Intolerancia a la Lactosa/epidemiología , Intolerancia a la Lactosa/genética , Intolerancia a la Lactosa/historia , Metano/metabolismo , Prevalencia
6.
Chem Immunol Allergy ; 101: 51-8, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26022864

RESUMEN

In young children, food allergy is usually acquired via the gastrointestinal tract and directed toward egg and milk. Adolescent and adult patients, however, mainly acquire food allergy via primary sensitization to inhalant allergens on the basis of cross-reactivity between proteins in inhalant sources and in food. This type of food allergy is frequently mediated by sensitization to broadly represented allergens, or so-called panallergens. Food allergic reactions in adult patients - similar to those in children - range in severity from very mild and local symptoms, as in contact urticaria of the oral mucosa, to systemic symptoms involving distal organs, to a fatal outcome. Plant foods, such as fruits, nuts, and vegetables, are the most prevalent allergenic foods in this age group.


Asunto(s)
Hipersensibilidad a los Alimentos/diagnóstico , Hipersensibilidad a los Alimentos/epidemiología , Adolescente , Adulto , Factores de Edad , Alérgenos/efectos adversos , Alérgenos/inmunología , Ambrosia/inmunología , Animales , Artemisia/inmunología , Betula/inmunología , Diagnóstico Diferencial , Disacáridos/efectos adversos , Disacáridos/inmunología , Hipersensibilidad a los Alimentos/inmunología , Histamina/inmunología , Humanos , Intolerancia a la Lactosa/diagnóstico , Intolerancia a la Lactosa/epidemiología , Intolerancia a la Lactosa/inmunología , Carne/efectos adversos , Poaceae/inmunología , Polen/efectos adversos , Polen/inmunología , Adulto Joven
7.
J Nutr Educ Behav ; 46(6): 554-9, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24502965

RESUMEN

OBJECTIVE: To determine attitudes, beliefs, and barriers related to adequate milk consumption in low-income women ages ≥ 60 years. METHODS: Nine focus groups were conducted with a convenience sample of 59 women at congregate meal sites in a metropolitan area. Grounded in Social Cognitive Theory, focus group questions were used to explore personal, behavioral, and environmental factors associated with milk consumption. RESULTS: Key response themes indicated a positive attitude for the taste of milk (except for low-fat), a primary belief that milk was important for bones and health, and a primary barrier of gastrointestinal side effects. CONCLUSIONS AND IMPLICATIONS: Knowledge regarding the benefits of milk and the dislike of its taste were not the primary reason for the lack of consumption. Instead, gastrointestinal side effects seemed to be the major barrier to adequate consumption. Future nutrition campaigns should test strategies for lactose intolerance management when communicating with low-income older women.


Asunto(s)
Dieta/efectos adversos , Fenómenos Fisiológicos Nutricionales del Anciano , Gastroenteritis/etiología , Conocimientos, Actitudes y Práctica en Salud , Lactasa/deficiencia , Intolerancia a la Lactosa/dietoterapia , Leche/efectos adversos , Autocuidado , Anciano , Animales , Autoevaluación Diagnóstica , Dieta/economía , Femenino , Grupos Focales , Asistencia Alimentaria , Servicios de Alimentación , Gastroenteritis/prevención & control , Humanos , Indiana , Lactasa/economía , Intolerancia a la Lactosa/diagnóstico , Intolerancia a la Lactosa/economía , Intolerancia a la Lactosa/fisiopatología , Persona de Mediana Edad , Leche/economía , Pobreza , Salud Urbana
8.
Complement Ther Clin Pract ; 18(2): 81-4, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22500843

RESUMEN

OBJECTIVE: To determine the short- and long-term effect of treatment in children with chronic abdominal pain (CAP). METHODS: A database with the results of H(2) breath test of children with CAP was created. All children with an abnormal test result were included and classified as small intestinal bacterial overgrowth (SIBO) or lactose intolerant (LTI). SIBO was treated with probiotics and LTI with a lactose-restricted diet. CAP was evaluated 5 months and 15 months after the test. RESULTS: 37 children (41%) were included. 17 LTI children (94%) improved after 5 months and 11 children (61%) after 15 months (P<0.05). Seven SIBO children improved after 5 months and 4 children after 15 months. In the combination group all 4 children improved after 5 months and 3 children after 15 months. CONCLUSION: Children with CAP caused by LTI or SIBO had less CAP after 5 months. This positive effect persists only in half of the children.


Asunto(s)
Dolor Abdominal/terapia , Síndrome del Asa Ciega/terapia , Intolerancia a la Lactosa/dietoterapia , Probióticos/uso terapéutico , Dolor Abdominal/dietoterapia , Dolor Abdominal/etiología , Adolescente , Síndrome del Asa Ciega/diagnóstico , Pruebas Respiratorias , Niño , Preescolar , Enfermedad Crónica , Bases de Datos Factuales , Carbohidratos de la Dieta/administración & dosificación , Femenino , Estudios de Seguimiento , Humanos , Hidrógeno/análisis , Lactante , Lactosa/administración & dosificación , Intolerancia a la Lactosa/diagnóstico , Prueba de Tolerancia a la Lactosa , Masculino , Estudios Retrospectivos , Factores de Tiempo , Resultado del Tratamiento
9.
Wien Med Wochenschr ; 162(5-6): 110-4, 2012 Mar.
Artículo en Alemán | MEDLINE | ID: mdl-22488034

RESUMEN

A 44 yr-old female with osteoporosis had no relevant gastrointestinal symptoms and did not avoid any specific food. However, after prescription of a lactose-rich calcium supplementation, clinical symptoms suspicious for lactose intolerance occurred, which were thereafter confirmed by a lactose tolerance test. Lactose intolerance may present with only slight or subtle symptoms. Drugs containing lactose may induce or increase gastrointestinal symptoms in patients with lactose intolerance. In case of gastrointestinal symptoms occurring after the initiation of drugs containing lactose, the possibility of lactose intolerance should be considered and tested by lactose tolerance test or genetic testing for the LCT (-13910) polymorphism. Due to the prevalence of about 15-25% lactose intolerance in the Austrian population, lactose free drugs should be prescribed as widely as possible.


Asunto(s)
Dolor Abdominal/etiología , Carbonato de Calcio/administración & dosificación , Carbonato de Calcio/efectos adversos , Diarrea/etiología , Excipientes/efectos adversos , Intolerancia a la Lactosa/diagnóstico , Lactosa/administración & dosificación , Lactosa/efectos adversos , Osteoporosis/tratamiento farmacológico , Absorciometría de Fotón , Adulto , Austria , Femenino , Pruebas Genéticas , Humanos , Intolerancia a la Lactosa/genética , Osteoporosis/diagnóstico , Polimorfismo Genético/genética
10.
Pediatrics ; 118(3): 1279-86, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16951027

RESUMEN

The American Academy of Pediatrics Committee on Nutrition presents an updated review of lactose intolerance in infants, children, and adolescents. Differences between primary, secondary, congenital, and developmental lactase deficiency that may result in lactose intolerance are discussed. Children with suspected lactose intolerance can be assessed clinically by dietary lactose elimination or by tests including noninvasive hydrogen breath testing or invasive intestinal biopsy determination of lactase (and other disaccharidase) concentrations. Treatment consists of use of lactase-treated dairy products or oral lactase supplementation, limitation of lactose-containing foods, or dairy elimination. The American Academy of Pediatrics supports use of dairy foods as an important source of calcium for bone mineral health and of other nutrients that facilitate growth in children and adolescents. If dairy products are eliminated, other dietary sources of calcium or calcium supplements need to be provided.


Asunto(s)
Calcio de la Dieta , Intolerancia a la Lactosa/dietoterapia , Intolerancia a la Lactosa/diagnóstico , Adolescente , Niño , Desarrollo Infantil , Preescolar , Registros de Dieta , Suplementos Dietéticos , Femenino , Humanos , Lactante , Recién Nacido , Lactasa/deficiencia , Masculino
11.
Fukuoka Igaku Zasshi ; 97(11): 322-50, 2006 Nov.
Artículo en Japonés | MEDLINE | ID: mdl-17228786

RESUMEN

Multiple cases with various types of pediatric malabsorption syndromes were evaluated. The clinical manifestations, laboratory findings, pathophysiology, and histopathological descriptions of each patient were analyzed in an effort to clear the pathogenesis of the malabsorption syndromes and the treatments were undertaken. The cases studied, included one patient with cystic fibrosis, two with lactose intolerance with lactosuria (Durand type), one with primary intestinal lymphangiectasia, two with familial hypobetalipoproteinemia, one with Hartnup disease, one with congenital chroride diarrhea, one with acrodermatitis enteropathica, one with intestinal nodular lymphoid hyperplasia (NLH), five with intractable diarrhea of early infancy and four with glycogenosis type Ia. Each case description and outcome is described below: 1. A 15-year-old Japanese boy with cystic fibrosis presented with severe symptoms, including pancreatic insufficiency, bronchiectasis, pneumothorax and hemoptysis. His prognosis was poor. Analysis of the CFTR genes of this patient revealed a homozygous large deletion from intron 16 to 17b. 2. In the sibling case of Durand type lactose intolerance, the subjects'disaccaridase activity of the small bowel, including lactase, were within normal limits. The results of per oral and per intraduodenal lactose tolerance tests confirmed lactosuria in both. These observations suggested, not only an abnormal gastric condition, but also duodenal and intestinal mucosal abnormal permeability of lactose. 3. In the case of primary intestinal lymphangiectasia, the subject had a lymphedematous right arm and hand, a grossly coarsened mucosal pattern of the upper gastrointestinal tract (identified via radiologic examination) and the presence of lymphangiectasia (confirmed via duodenal mucosal biopsy). The major laboratory findings were hypoalbuminemia, decreased immunoglobulin levels and lymphopenia resulting from loss of lymph fluid and protein into the gastro-intestinal tract. 4. In two cases of heterozygous familial hypobetalipoproteinemia, serum total cholesterol and betalipoprotein levels were very low. The subjects presented with symptoms and signs of acanthocytosis and fat malabsorption. Further, one subject had neurological abnormalities such as mental retardation and severe convulsions. Treatment with MCT formula diet corrected the lipid malabsorption. 5. A 5-year-old girl presented with pellagra-like rashes, mental retardation and cerebellar ataxia. An oral tryptophan (Trp) and dipeptide (Trp-Phe) loading test were conducted and the renal clearance of amino acids was also evaluated in this patient and in controls. Following the oral Trp loading test, plasma levels of Trp indicated a lower peak in the case, reaching a maximum at 60 minutes. On the other hand, the oral dipeptide (Trp-Phe) loading test in the Hartnup patient showed the peak Trp plasma level was the same as the control subjects. The renal clearance of neutral amino acids in this case increased to levels 5 to 35 times normal. 6. In the case of congenital chloride diarrhea, the subject had secondary lactose intolerance, dehydration, hyponatremia, hypokalemia, hypochloremia, hyperreninemia and metabolic alkalosis. The chloride content of her fecal fluid was very high. The concentrations were 89-103 mEq/l. In contrast, her urine was chloride-free. The subject's growth and development improved after treatment with lactose free formura and oral replacement of the fecal loses of water, NaCl and KCl. Unfortunately, the patient died of a small bowel intussusception. The kidney histopathological finding was juxtaglomerular hyperplasia by a necropsy. 7. In the case of acrodermatitis enteropathica, the subject had characteristic skin lesions, low serum zinc levels and ALPase activity. An oral ZnSO4 loading test and intestinal mucosal histology by a peroral biopsy were conducted. The serum zinc peak level was 2 hours after the oral ZnSO4 loading test. Infant formula alone could not maintain normal serum zinc ranges. Light microscopic studies of the intestinal villous architecture showed a normal pattern. However, ultrastructual examination of several epithelial cells revealed numerous intracellular vesicles. After zinc therapy, these changes were decreased. The lesions were postulated as the secondary result of zinc deficiency. 8. A 12-year-old girl presented with hypogammaglobulinemia, recurrent infections, chronic diarrhea and intestinal NLH. A barium meal and follow-through examination showed multiple nodules throughout the stomach and intestine. The nodules, all uniform in size, were 2 mm diameter. The barium enema did not show NLH in the colon. Mucosal biopsy of the stomach and jejunum revealed the typical histology of NLH in the lamina propria. Also, achlorhydria was present in this patient and her serum gastrin levels were very high; 315-775 pg/ml. 9. In 4 cases of intractable diarrhea in early infancy (by Avery G B), a jejunal biopsy showed shortening villi and nonspecific enterocolitis. Some patients were found with only low lactase or low lactase and sucrase levels. An electron microscope analysis of the small bowel in 2 cases showed alterations: increased pinocytosis in microvillus membranes and lysosomes by endocytosis of undigested macromolecular substances. I postulated that the stated evidence was causative of this clinical profile. 10. I frequently observed diarrhea as a clinical manifestation in glycogenosis type Ia and lipid malabsorption in one case. The light and electron photomicrographs showed intestinal absorption cells with the glycogen deposits in the inferior devision of nuclei.


Asunto(s)
Síndromes de Malabsorción/etiología , Síndromes de Malabsorción/terapia , Acrodermatitis/complicaciones , Acrodermatitis/diagnóstico , Acrodermatitis/terapia , Adolescente , Enfermedad de Castleman/complicaciones , Enfermedad de Castleman/diagnóstico , Enfermedad de Castleman/terapia , Niño , Preescolar , Fibrosis Quística/complicaciones , Fibrosis Quística/diagnóstico , Fibrosis Quística/terapia , Diarrea/complicaciones , Diarrea/congénito , Diarrea/diagnóstico , Diarrea/terapia , Diarrea Infantil/complicaciones , Diarrea Infantil/diagnóstico , Diarrea Infantil/terapia , Femenino , Enfermedad del Almacenamiento de Glucógeno Tipo I/complicaciones , Enfermedad del Almacenamiento de Glucógeno Tipo I/diagnóstico , Enfermedad del Almacenamiento de Glucógeno Tipo I/terapia , Enfermedad de Hartnup/complicaciones , Enfermedad de Hartnup/diagnóstico , Enfermedad de Hartnup/terapia , Humanos , Hipobetalipoproteinemia Familiar por Apolipoproteína B/complicaciones , Hipobetalipoproteinemia Familiar por Apolipoproteína B/diagnóstico , Hipobetalipoproteinemia Familiar por Apolipoproteína B/terapia , Lactante , Recién Nacido , Intolerancia a la Lactosa/complicaciones , Intolerancia a la Lactosa/diagnóstico , Intolerancia a la Lactosa/terapia , Linfangiectasia Intestinal/complicaciones , Linfangiectasia Intestinal/diagnóstico , Linfangiectasia Intestinal/terapia , Masculino
12.
J Am Coll Nutr ; 24(1): 51-7, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15670985

RESUMEN

OBJECTIVE: To determine methods of diagnosis, symptoms, and calcium intake from food and supplements for individuals with self-reported lactose intolerance. METHODS/DESIGN: Cross-sectional survey using a mailed questionnaire. SUBJECTS/SETTING: A convenience sample of 189 adults with self-reported lactose intolerance living in the metropolitan area of Vancouver Canada responded to posters or advertisements, and 159 returned completed questionnaires. MEASURES OF OUTCOME: Methods of diagnosis, symptoms experienced and their severity were self-reported. Estimated calcium intake from food and supplements was assessed using a food frequency questionnaire. Data were analyzed using descriptive statistics, chi-square, Pearson correlation analysis, t-tests and Analysis of Variance. RESULTS: Participants were 47 +/- 15 years of age; 72% female and 28% male; 67% Caucasian; and 54% had self-diagnosed their lactose intolerance. Of the 42% diagnosed by a physician, only 10% had been diagnosed by valid tests. Mean estimated food calcium intake was 591 +/- 382 mg/d and did not differ between those who were self- or physician-diagnosed. Only 11.5% of participants met their age-appropriate Adequate Intake (AI) from food calcium sources alone. Calcium supplements were used by 65% and provided an average of 746 +/- 703 mg calcium/day to those who used them; mean intakes of this group met the AI. CONCLUSIONS: Calcium intake from food sources alone is inadequate to meet the AI in individuals with self-reported lactose intolerance. Physicians managing lactose intolerance need current information on how the AI can be met through appropriate food choices and possible supplementation.


Asunto(s)
Calcio de la Dieta/administración & dosificación , Productos Lácteos/efectos adversos , Intolerancia a la Lactosa/fisiopatología , Necesidades Nutricionales , Adulto , Anciano , Anciano de 80 o más Años , Estudios Transversales , Suplementos Dietéticos , Femenino , Humanos , Intolerancia a la Lactosa/diagnóstico , Masculino , Persona de Mediana Edad , Autorrevelación , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios
14.
Am Fam Physician ; 65(9): 1845-50, 2002 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-12018807

RESUMEN

Persons with lactose intolerance are unable to digest significant amounts of lactose because of a genetically inadequate amount of the enzyme lactase. Common symptoms include abdominal pain and bloating, excessive flatus, and watery stool following the ingestion of foods containing lactose. Lactase deficiency is present in up to 15 percent of persons of northern European descent, up to 80 percent of blacks and Latinos, and up to 100 percent of American Indians and Asians. A sizable number of adults believe they are lactose intolerant but do not actually have impaired lactose digestion, and some persons with lactase deficiency can tolerate moderate amounts of ingested lactose. A diagnosis of lactose intolerance can usually be made with a careful history supported by dietary manipulation. If necessary, diagnosis can be confirmed by using a breath hydrogen or lactose tolerance test. Treatment consists primarily of avoiding lactose-containing foods. Lactase enzyme supplements may be helpful. The degree of lactose malabsorption varies greatly among patients with lactose intolerance, but most of them can ingest up to 12 oz of milk daily without symptoms. Lactose-intolerant patients must ensure adequate calcium intake.


Asunto(s)
Intolerancia a la Lactosa/diagnóstico , Intolerancia a la Lactosa/terapia , Calcio de la Dieta/administración & dosificación , Medicina Familiar y Comunitaria , Humanos , Lactasa , Intolerancia a la Lactosa/dietoterapia , beta-Galactosidasa/uso terapéutico
15.
Artículo en Alemán | MEDLINE | ID: mdl-11799301

RESUMEN

BACKGROUND: Because nutritional intolerances generally are difficult to be diagnosed, Applied Kinesiology (AK) often is discussed as an alternative in this field. AIM: The uncertain scientific situation makes it necessary to assess the diagnostic value of AK. The method was compared with established laboratory tests such as RAST, lactose breath hydrogen test and a specific IgG test (Cytolisa). METHODS: 315 children and adolescents, 0-17 years old, with different chronic diseases such as headache, abdominal pain, chronic eczema, hyperactivity, and bronchial asthma were studied by means of AK for 2 years. RESULTS: We found a moderate test-retest reliability (intraclass-kappa 0.62) but no inter-tester reliability (intraclass-kappa -0.01). Moreover, there was no statistically significant agreement with either RAST and Cytolisa (sensitivity 73.6%, specificity 45.2%) or lactose breath hydrogen test (sensitivity 77.1%, specificity 43.2%). CONCLUSIONS: In general, AK cannot be recommended for diagnosing nutritional intolerance. However, due to its high sensitivity, it could be a valuable tool to give some preliminary results.


Asunto(s)
Hipersensibilidad a los Alimentos/diagnóstico , Quinesiología Aplicada/métodos , Adolescente , Pruebas Respiratorias/métodos , Niño , Preescolar , Productos Lácteos/efectos adversos , Femenino , Humanos , Hidrógeno , Inmunoglobulina G/sangre , Lactante , Recién Nacido , Intolerancia a la Lactosa/diagnóstico , Masculino , Estado Nutricional , Prueba de Radioalergoadsorción , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
16.
Postgrad Med ; 104(3): 109-11, 115-6, 122-3, 1998 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9742907

RESUMEN

Lactose intolerance is widespread, with adult-type hypolactasia being the predominant cause of lactose malabsorption. Daily ingestion of less than 240 mL of milk is well tolerated by most lactose-intolerant adults. Some persons with normal lactase activity may become symptomatic on consumption of products containing lactose. Lactose maldigestion may coexist in adults with irritable bowel syndrome and in children with recurrent abdominal pain. Management consists primarily of dietary changes. People who avoid dairy products should receive calcium supplementation and should be advised to read ingredient labels carefully. Several lactase replacement products are available, but their efficacy varies.


Asunto(s)
Intolerancia a la Lactosa/diagnóstico , Adolescente , Adulto , Productos Lácteos/efectos adversos , Humanos , Lactasa , Intolerancia a la Lactosa/epidemiología , Intolerancia a la Lactosa/terapia , Prevalencia , beta-Galactosidasa/uso terapéutico
18.
CMAJ ; 139(8): 711-8, 1988 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-3048623

RESUMEN

Dietary considerations play an important role in the diagnosis, treatment and management of immunologic and nonimmunologic reactions to foods. Food diaries and trial elimination diets may prove helpful in identifying the responsible foods. Elimination diets must be monitored carefully for nutritional adequacy and should be used no longer than absolutely necessary; in some instances appropriate vitamin and mineral supplementation may be necessary. Ideally the identification of foods that provoke symptoms should be confirmed by means of double-blind challenge testing. Avoidance of some problem foods is unlikely to cause nutritional problems, but the practical and nutritional implications of allergies to staple foods such as cow's milk, eggs and wheat are far greater. Nonimmunologic adverse reactions that may mimic food allergic reactions include gastrointestinal disorders, sensitivity to food additives and psychologically based adverse reactions. There may be some degree of tolerance in metabolic disorders, which makes dietary management easier. Sensitivity to food additives necessitates careful scrutiny of food labels. In psychologic adverse reactions to foods, several foods are often involved, which increases the risk of nutritional problems.


Asunto(s)
Hipersensibilidad a los Alimentos/dietoterapia , Adulto , Anafilaxia/etiología , Enfermedad Celíaca/diagnóstico , Niño , Diagnóstico Diferencial , Conducta Alimentaria/psicología , Femenino , Aditivos Alimentarios/efectos adversos , Hipersensibilidad a los Alimentos/diagnóstico , Hipersensibilidad a los Alimentos/etiología , Hipersensibilidad a los Alimentos/psicología , Etiquetado de Alimentos , Humanos , Lactante , Intolerancia a la Lactosa/diagnóstico
19.
J Pediatr Gastroenterol Nutr ; 4(2): 196-8, 1985 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-3989620

RESUMEN

Lactose malabsorption is not a cause of diarrhea during phototherapy. Jaundiced neonates under phototherapy develop diarrhea or loose stools during the treatment. These phenomena were attributed to an induced lactase deficiency caused by bilirubin breakdown products. We investigated lactose malabsorption in 59 neonates--29 normals and 30 jaundiced under phototherapy. Five-hour hydrogen breath tests were performed. Preprandial and postprandial (at 30, 60, 120, 180, 240, and 300 min) expired air samples were analyzed for hydrogen. Ten controls and five jaundiced neonates had positive hydrogen breath tests. Eighteen controls and 16 neonates under phototherapy had preprandial hydrogen (concentrations above 5 ppm). In our hands, lactase deficiency and lactose malabsorption were not induced by phototherapy. Lactase deficiency is therefore not the cause of diarrhea associated with phototherapy.


Asunto(s)
Diarrea Infantil/etiología , Ictericia Neonatal/terapia , Intolerancia a la Lactosa/diagnóstico , Fototerapia , Pruebas Respiratorias , Femenino , Humanos , Hidrógeno/análisis , Recién Nacido , Intolerancia a la Lactosa/complicaciones , Masculino
20.
Postgrad Med ; 75(8): 82, 86-7, 1984 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-6728746

RESUMEN

Patients with chronic diarrhea should be carefully questioned about their diet. A correlation may be found between gastrointestinal symptoms and the ingestion of coffee, milk, or sugars such as sorbitol and fructose. If the offending agent can be identified and withdrawn from the diet, the diarrhea will stop and further evaluation can be avoided.


Asunto(s)
Café/efectos adversos , Diarrea/etiología , Dieta , Carbohidratos de la Dieta/efectos adversos , Anamnesis , Enfermedad Crónica , Humanos , Intolerancia a la Lactosa/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA